DA
DCF Advisers Portfolio holdings
AUM
$208M
This Quarter Return
+10.62%
1 Year Return
+21.52%
3 Year Return
+75.42%
5 Year Return
+129.34%
10 Year Return
–
AUM
$199M
AUM Growth
+$199M
(+8.1%)
Cap. Flow
-$3.11M
Cap. Flow
% of AUM
-1.56%
Top 10 Holdings %
Top 10 Hldgs %
53.98%
Holding
81
New
1
Increased
18
Reduced
14
Closed
8
Top Buys
| 1 |
AbbVie
ABBV
|
$2.92M |
| 2 |
Intel
INTC
|
$1.03M |
| 3 |
IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
|
$915K |
| 4 |
AT&T
T
|
$800K |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$758K |
Top Sells
| 1 |
Verizon
VZ
|
$2.6M |
| 2 |
Alibaba
BABA
|
$2.15M |
| 3 |
VanEck Gold Miners ETF
GDX
|
$1.92M |
| 4 |
Advanced Micro Devices
AMD
|
$1.44M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
$1.05M |
Sector Composition
| 1 | Healthcare | 49.6% |
| 2 | Technology | 16.99% |
| 3 | Communication Services | 8.96% |
| 4 | Financials | 5.94% |
| 5 | Consumer Discretionary | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ITCI
1
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $18.8M | 7.62% | 359,000 -20,000 | -5% | -$1.05M |
|
2
Micron Technology
MU
$133B
| $16.5M | 6.7% | 177,500 | – | – |
|
|
3
AbbVie
ABBV
$372B
| $13.4M | 5.45% | 99,318 +21,568 | +28% | +$2.92M |
|
4
Alphabet (Google) Class C
GOOG
$2.58T
| $12.6M | 5.1% | 4,350 | – | – |
|
|
5
Regeneron Pharmaceuticals
REGN
$61.5B
| $10.9M | 4.4% | 17,200 +1,200 | +8% | +$758K |
|
6
Xencor
XNCR
$580M
| $9.7M | 3.93% | 241,763 +11,763 | +5% | +$472K |
|
7
argenx
ARGX
$43.6B
| $8.76M | 3.55% | 25,000 | – | – |
|
8
Bank of America
BAC
$376B
| $6.47M | 2.62% | 145,500 -4,500 | -3% | -$200K |
|
9
Incyte
INCY
$16.5B
| $5.14M | 2.08% | 70,000 | – | – |
|
10
General Motors
GM
$55.8B
| $4.98M | 2.02% | 85,000 -5,000 | -6% | -$293K |
|
|
11
Advanced Micro Devices
AMD
$264B
| $4.32M | 1.75% | 30,000 -10,000 | -25% | -$1.44M |
|
12
SPDR Gold Trust
GLD
$107B
| $4.27M | 1.73% | 25,000 +2,500 | +11% | +$427K |
|
13
Turning Point Brands
TPB
$1.79B
| $4.23M | 1.71% | 111,926 +10,926 | +11% | +$413K |
|
14
Citigroup
C
$178B
| $4.11M | 1.67% | 68,000 +3,000 | +5% | +$181K |
|
15
Pfizer
PFE
$141B
| $3.84M | 1.56% | 65,000 | – | – |
|
16
Oracle
ORCL
$635B
| $3.71M | 1.5% | 42,500 +2,500 | +6% | +$218K |
|
|
17
VanEck Gold Miners ETF
GDX
$19B
| $3.68M | 1.49% | 115,000 -60,000 | -34% | -$1.92M |
|
18
Ford
F
$46.8B
| $3.51M | 1.42% | 168,750 +36,250 | +27% | +$753K |
|
19
iShares Gold Trust
IAU
$50.6B
| $3.48M | 1.41% | 100,000 | – | – |
|
20
Eli Lilly
LLY
$657B
| $3.11M | 1.26% | 11,250 | – | – |
|
21
Alnylam Pharmaceuticals
ALNY
$58.5B
| $3.05M | 1.24% | 18,000 +500 | +3% | +$84.8K |
|
22
Prothena Corp
PRTA
$441M
| $2.96M | 1.2% | 60,000 | – | – |
|
23
Amgen
AMGN
$155B
| $2.87M | 1.16% | 12,750 +1,500 | +13% | +$337K |
|
|
AOD
24
abrdn Total Dynamic Dividend Fund
AOD
$963M
| $2.65M | 1.07% | 259,000 | – | – |
|
|
25
Verizon
VZ
$186B
| $2.6M | 1.05% | 50,000 -50,000 | -50% | -$2.6M |
|